Opko Health Inc (OPK)

[bulldurham]

In Opko Health's most recent presentation at the Annual JP Morgan Biotech conference they displayed some information that many investors appeared to not have been aware of thus far. The presentation discussed that their new diagnostic technology is in fact not only capable of diagnosing through blood samples, but can also use samples of urine, saliva, sweat, tears, semen, amniotic fluid, spinal fluid and serum. I considered this valuable info since OPK also discussed its diagnostic system testing various other areas such as STDs, fertility, cardiology and more. Further interesting news that OPK disclosed is that they are projecting to launch their 4Kscore™ LDT for prostate cancer by Q2 2013 in the US.